LIANBIO's ticker is and the CUSIP is 53000N108. A total of 45 filers reported holding LIANBIO in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,873 | -37.3% | 2,598,766 | -4.1% | 0.00% | 0.0% |
| Q2 2023 | $6,180 | +24.9% | 2,710,214 | +6.8% | 0.00% | 0.0% |
| Q1 2023 | $4,949 | +12.5% | 2,537,609 | -5.4% | 0.00% | 0.0% |
| Q4 2022 | $4,398 | -99.9% | 2,681,497 | -5.0% | 0.00% | 0.0% |
| Q3 2022 | $5,618,000 | +22.3% | 2,822,857 | +32.7% | 0.00% | 0.0% |
| Q2 2022 | $4,594,000 | -43.2% | 2,126,878 | -5.2% | 0.00% | 0.0% |
| Q1 2022 | $8,090,000 | -39.8% | 2,242,389 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $13,432,000 | – | 2,242,389 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,282,084 | $4,929,000 | 4.16% |
| Perceptive Advisors | 56,560,211 | $122,170,000 | 3.83% |
| SCHF (GPE), LLC | 937,500 | $2,025,000 | 2.99% |
| VR Adviser, LLC | 5,378,341 | $11,617,000 | 2.29% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $7,159,000 | 0.52% |
| Affinity Asset Advisors, LLC | 450,000 | $972,000 | 0.41% |
| Altium Capital Management LP | 315,191 | $681,000 | 0.27% |
| RA Capital Management | 4,622,574 | $9,985,000 | 0.27% |
| 22NW, LP | 141,223 | $305,000 | 0.16% |
| Logos Global Management LP | 394,486 | $852,000 | 0.16% |